Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response
preprint
OA: gold
CC0
Abstract
Abstract Endometriosis (EM), characterized by the presence of endometrial-like tissue outside the uterus, is the leading cause of chronic pelvic pain and infertility in females of reproductive age. Despite its high prevalence, the molecular mechanisms underlying EM pathogenesis remain poorly understood. The endocannabinoid system (ECS) is known to influence several cardinal features of this complex disease including pain, vascularization, and overall lesion survival, but the exact mechanisms are not known. Utilizing CNR1 knockout (k/o), CNR2 k/o and wild type (WT) mouse models of EM, we reveal contributions of ECS and these receptors in disease initiation, progression, and immune modulation. Particularly, we identified EM-specific T cell dysfunction in the CNR2 k/o mouse model of EM. We also demonstrate the impact of decidualization-induced changes on ECS components, and the unique disease-associated transcriptional landscape of ECS components in EM. Imaging Mass Cytometry (IMC) analysis revealed distinct features of the microenvironment between CNR1, CNR2, and WT genotypes in the presence or absence of decidualization. This study, for the first time provides an in-depth analysis of the involvement of the ECS in EM pathogenesis and lays the foundation for the development of novel therapeutic interventions to alleviate the burden of this debilitating condition.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (57)
- Altered differentiation of endometrial mesenchymal stromal fibroblasts is associated with endometriosis susceptibility via openalex
- Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis via openalex
- Endocannabinoids modulate apoptosis in endometriosis and adenomyosis via openalex
- Endometriosis and infertility: Insights into the causal link and management strategies via openalex
- Exacerbation of Endometriosis Due To Regulatory T-Cell Dysfunction via openalex
- Implications of dysregulated endogenous cannabinoid family members in the pathophysiology of endometriosis via openalex
- Macrophages alternatively activated by endometriosis-exosomes contribute to the development of lesions in mice via openalex
- NLRP3 Inflammasome Activation of Mast Cells by Estrogen via the Nuclear-Initiated Signaling Pathway Contributes to the Development of Endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Potential involvement of the immune system in the development of endometriosis via openalex
- Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications via openalex
- Synergy between Th1 and Th2 responses during endometriosis: A review of current understanding via openalex
- Synthetic Cannabinoid Agonist WIN 55212-2 Targets Proliferation, Angiogenesis, and Apoptosis via MAPK/AKT Signaling in Human Endometriotic Cell Lines and a Murine Model of Endometriosis via openalex
- The dysregulation of leukemia inhibitory factor and its implications for endometriosis pathophysiology via openalex
- The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders via openalex
- T helper (Th)1, Th2, and Th17 interleukin pathways in infertile patients with minimal/mild endometriosis via openalex
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. via openalex
- W2911040443 via openalex
- W2924312265 via openalex
- W2984472267 via openalex
- W3003331854 via openalex
- W3091593026 via openalex
- W3157835721 via openalex
- W3213342965 via openalex
- W3214596602 via openalex
- W4211081176 via openalex
- W4213013416 via openalex
- W4244006029 via openalex
- W4281676448 via openalex
- W4318826747 via openalex
- W6755810978 via openalex
- W6757815128 via openalex
- W6794978677 via openalex
- W6798098907 via openalex
- W6801572111 via openalex
- W6802599743 via openalex
- W6804324874 via openalex
- W6807516075 via openalex
- W6808270723 via openalex
- W1886084954 via openalex
- W6845911302 via openalex
- W1969221886 via openalex
- W2035772285 via openalex
- W2076350583 via openalex
- W2081642281 via openalex
- W2082084857 via openalex
- W2087674201 via openalex
- W2119975890 via openalex
- W2123698191 via openalex
- W2142535292 via openalex
- W2145290390 via openalex
- W2460083407 via openalex
- W2515727339 via openalex
- W2532412189 via openalex
- W2790631595 via openalex
- W2884952568 via openalex
- W2909683870 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK